This topic contains a solution. Click here to go to the answer

Author Question: How many half lives of a drug does it take to eliminate 50 of the drug from the body? a. One. b. ... (Read 25 times)

lunatika

  • Hero Member
  • *****
  • Posts: 548
How many half lives of a drug does it take to eliminate 50 of the drug from the body?
 
  a. One.
  b. Two.
  c. Four.
  d. Five.

Question 2

Which of the following does not facilitate a drug's passage across the bloodbrain barrier?
 
  a. Blood-brain barrier transporter mechanisms?
  b. Increased lipid solubility.
  c. The ionized form of a drug.
  d. Small molecular size.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

nathang24

  • Sr. Member
  • ****
  • Posts: 314
Answer to Question 1

a

Answer to Question 2

c




lunatika

  • Member
  • Posts: 548
Reply 2 on: Jun 22, 2018
Thanks for the timely response, appreciate it


deja

  • Member
  • Posts: 332
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

The Romans did not use numerals to indicate fractions but instead used words to indicate parts of a whole.

Did you know?

Signs of depression include feeling sad most of the time for 2 weeks or longer; loss of interest in things normally enjoyed; lack of energy; sleep and appetite disturbances; weight changes; feelings of hopelessness, helplessness, or worthlessness; an inability to make decisions; and thoughts of death and suicide.

Did you know?

Patients who have undergone chemotherapy for the treatment of cancer often complain of a lack of mental focus; memory loss; and a general diminution in abilities such as multitasking, attention span, and general mental agility.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

For a complete list of videos, visit our video library